Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury
NCT04810858 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220
Last updated 2026-03-31
Summary
This study applies a hypothesis-driven approach to examine the effects of chronic marijuana use on HIV-associated inflammation and its subsequent impacts on central nervous system function, with the goal of identifying the mechanisms through which cannabinoids modulate neurological disorders and other comorbidities in persons with HIV.
Conditions
- Cannabis
- HIV
- Inflammation
- Cognition
- Neuroimaging
Interventions
- OTHER
-
Multimodal, multi-parametric MRI
The investigators will use multimodal, multi-parametric sequences to investigate neuroinflammatory and neurodegenerative processes in vivo. Participants will be assessed three times over 2 years.
- OTHER
-
Immune and cytokine profiling
Blood samples will be collected for immune and cytokine profiling. Participants will be assessed three times over 2 years.
- BEHAVIORAL
-
Neuropsychological testing
Participants will have neuropsychological testing three times over 2 years.
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Christina S Meade, PhD · Wake Forest University Health Sciences
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Max Age
- 59 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-08-18
- Primary Completion
- 2027-05-31
- Completion
- 2027-05-31
Countries
- United States
Study Locations
More Related Trials
-
Oral Dronabinol-HIV
NCT06034314 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Acute Neural and Immune Effects of Alcohol in People Living With HIV Infection
NCT04050735 ·Status: COMPLETED ·Phase: NA
-
Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS
NCT00079560 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain
NCT03099005 ·Status: COMPLETED ·Phase: PHASE2
-
Substance Use Disorders in HIV People of Cameroon
NCT02356185 ·Status: UNKNOWN
-
Neurobehavioral Model of HIV in Injection Drug Users
NCT00198861 ·Status: COMPLETED
-
Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV
NCT05209867 ·Status: COMPLETED ·Phase: PHASE4
-
Inflammation and Depression in People With HIV
NCT05849038 ·Status: RECRUITING ·Phase: PHASE2
-
The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
NCT01034800 ·Status: COMPLETED
-
Stimulant Use and Methylation in HIV
NCT05916989 ·Status: COMPLETED
-
Brain Imaging for HIV-Associated Thinking and Mood Disorders
NCT01692236 ·Status: TERMINATED
-
Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients
NCT05306249 ·Status: COMPLETED ·Phase: PHASE2
-
Neural Correlates of Working Memory Training for HIV Patients
NCT02602418 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Attentional Functioning in Children With HIV-1 Infection
NCT00001497 ·Status: COMPLETED
-
Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
NCT01227044 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prevalence of Substance Abuse Among Anti-retroviral Treatment Naive Patients Positive for HIV Antibodies
NCT04847388 ·Status: COMPLETED
-
SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy
NCT05586581 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
To Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection
NCT00959166 ·Status: COMPLETED ·Phase: NA
-
Effect of Galantamine on Inflammation and Cognition
NCT03384784 ·Status: COMPLETED ·Phase: PHASE2
-
CNS (Central Nervous System) Viral Dynamics and Cellular Immunity During AIDS
NCT00583167 ·Status: COMPLETED
-
Thinking and Memory Problems in People With HIV
NCT01875588 ·Status: RECRUITING
-
Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study
NCT02592174 ·Status: COMPLETED ·Phase: NA
-
Effects of Anti-HIV Therapy on Nervous System Function
NCT00432003 ·Status: COMPLETED
-
Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users
NCT01108679 ·Status: COMPLETED
-
Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth
NCT00107029 ·Status: COMPLETED